EFM-192B(人乳腺癌细胞)-常用生化试剂-试剂-生物在线
上海雅吉生物科技有限公司
EFM-192B(人乳腺癌细胞)

EFM-192B(人乳腺癌细胞)

商家询价

产品名称: EFM-192B(人乳腺癌细胞)

英文名称: EFM-192B

产品编号: RE59712

产品价格: 0

产品产地: 中国

品牌商标: 雅吉生物

更新时间: null

使用范围: null

上海雅吉生物科技有限公司
  • 联系人 :
  • 地址 : 上海市闵行区元江路5500号第1幢5658室
  • 邮编 :
  • 所在区域 : 上海
  • 电话 : 158****3937 点击查看
  • 传真 : 点击查看
  • 邮箱 : yajikit@163.com

 
Synonyms: EFM-192B
Background: established from the pleural effusion of the left side (14 days after EFM-192A) of a 46-year-old Caucasian woman with breast adenocarcinoma; cells were described in the literature to overexpress the erB-2 gene; sister cell lines EFM-192A and -192C show differences in molecular aspects
Species: human (Homo sapiens)
Tissue: breast  
Disease: breast carcinoma
Gender: N/A 
Morphology: epitheloid adherent cells growing as monolayers
Growth Mode: N/A 
Doubling Time: ca. 4-5 days
DNA Profile: N/A
 Cell Line Authentication Service
Culture Medium: PMI-1640+20%FBS
We strongly suggest to purchase the complete medium from .
Cryopreservation medium: 90%FBS+10%DMSO
Mycoplasma: negative in DAPI, microbiological culture, RNA hybridization assays
Immunology: cytokeratin +, cytokeratin-7 +, cytokeratin-8 -, cytokeratin-17 +, cytokeratin-18 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin -
Fingerprint: same DNA profile as EFM-192A/EFM-192C using multiplex PCR of minisatellite markers
Species: confirmed as human with IEF of LDH, MDH, NP
Cytogenetics: human heteroploid hypotriploid karyotype with 13% polyploidy - 62(58-62)<3n>XXX/XX, -X, +2, +4, +6, -7, -8, -8, -10, -11, -12, +14, +16, -17, -17, -17, -18, -18, -19, -20, -21, -22, +8mar, add(1)(p22-31), add(2)(q?35), del(3)(p22), add(5)(p15), del(6)(q25), add(10)(p11), add(13)(q32), add(14)(p12), add(15)(p12), der(15)t(10;15)(q11;p12), der(20)t(1;20)(q24;q12/13), der(21)t(7;21)(q11;p12)x2 - most cells carry a small ring and 1-2 large submetacentric 15p+ markers - closely related to EFM-192A - apparent ch 17 nullisomy
Virus   ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HHV-8 -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV -